Kezar Life Sciences Inc (KZR) Insider Trading
- $24,811,523.12
- $2,042,919.20
- Feb. 6, 2023
- Morningside Venture Investment
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Feb. 6, 2023 | Major Shareholder | 40,000 | $6.88 | Sell | $275,200.00 | |
| Feb. 3, 2023 | Major Shareholder | 25,000 | $7.15 | Sell | $178,750.00 | |
| Jan. 30, 2023 | Major Shareholder | 30,000 | $6.91 | Sell | $207,300.00 | |
| Jan. 25, 2023 | Major Shareholder | 50,000 | $6.85 | Sell | $342,500.00 | |
| Jan. 23, 2023 | Major Shareholder | 80,000 | $6.81 | Sell | $544,800.00 | |
| Jan. 17, 2023 | Major Shareholder | 6,114 | $6.79 | Sell | $41,514.06 | |
| Jan. 12, 2023 | Major Shareholder | 5,000 | $6.77 | Sell | $33,850.00 | |
| Jan. 5, 2023 | Major Shareholder | 12,162 | $6.97 | Sell | $84,769.14 | |
| Oct. 3, 2022 | Major Shareholder | 28,700 | $8.78 | Sell | $251,986.00 | |
| March 21, 2022 | Director | 20,000 | $14.77 | Buy | $295,400.00 | |
| March 18, 2022 | Director | 60,000 | $16.74 | Buy | $1,004,400.00 | |
| Jan. 3, 2022 | Director | 5,000 | $16.45 | Sell | $82,250.00 | |
| June 11, 2020 | Major Shareholder | 1,454,545 | $5.50 | Buy | $7,999,997.50 | |
| June 11, 2020 | Director | 100,000 | $4.84 | Buy | $484,000.00 | |
| Feb. 4, 2020 | SVP | 5,769 | $3.00 | Buy | $17,307.00 | |
| Feb. 4, 2020 | Major Shareholder | 3,800,000 | $2.60 | Buy | $9,880,000.00 | |
| Feb. 4, 2020 | Director | 120,846 | $3.00 | Buy | $362,538.00 | |
| Feb. 4, 2020 | CEO | 38,461 | $3.00 | Buy | $115,383.00 | |
| Feb. 4, 2020 | CFO | 15,384 | $3.00 | Buy | $46,152.00 | |
| Nov. 13, 2019 | CFO | 800 | $2.76 | Buy | $2,208.00 | |
| Nov. 1, 2019 | Insider | 110,000 | $0.20 | Buy | $22,000.00 | |
| Oct. 10, 2019 | CEO | 1,000 | $3.29 | Buy | $3,290.00 | |
| Aug. 20, 2019 | CFO | 200 | $4.42 | Buy | $884.00 | |
| Aug. 20, 2019 | SVP | 350 | $4.41 | Buy | $1,543.50 | |
| Aug. 13, 2019 | CEO | 2,000 | $4.66 | Buy | $9,320.00 | |
| Aug. 13, 2019 | Insider | 5,000 | $4.61 | Buy | $23,050.00 | |
| Aug. 9, 2019 | Insider | 5,000 | $4.97 | Buy | $24,850.00 | |
| Aug. 9, 2019 | CFO | 500 | $4.82 | Buy | $2,410.00 | |
| Aug. 9, 2019 | CEO | 1,250 | $5.11 | Buy | $6,387.50 | |
| Aug. 9, 2019 | SVP | 1,020 | $4.96 | Buy | $5,059.20 | |
| July 26, 2019 | CFO | 500 | $5.67 | Buy | $2,835.00 | |
| July 22, 2019 | SVP | 431 | $5.82 | Buy | $2,508.42 | |
| June 25, 2018 | Major Shareholder | 250,000 | $15.00 | Buy | $3,750,000.00 | |
| June 25, 2018 | Director | 50,000 | $15.00 | Buy | $750,000.00 |
Insiders are both buying and selling Kezar Life Sciences Inc stock.
The insider traders at Kezar Life Sciences Inc are: Morningside Venture Investment, Marc Belsky, Franklin M Berger, Vassiliki Economides, John Franklin Fowler, Christopher J Kirk, Michael Kauffman, Middleton Angus, and Equal Talent Investments Ltd
The most active insider trader at Kezar Life Sciences Inc is Morningside Venture Investment with 11 trades.
Morningside Venture Investment has sold the most Kezar Life Sciences Inc stock with a total value of $2,235,869.20.
Morningside Venture Investment has bought the most Kezar Life Sciences Inc stock with a total value of $23,510,000.00.
The most recent insider trade for Kezar Life Sciences Inc was on Feb. 6, 2023.
The single biggest insider buy for Kezar Life Sciences Inc was from Morningside Venture Investment with a total value of $9,880,000.00 on Feb. 4, 2020.
The single biggest insider sell for Kezar Life Sciences Inc was from Morningside Venture Investment with a total value of $544,800.00 on Jan. 23, 2023.